Weakened cholinergic blockade of inflammation associates with diabetes-related depression

Molecular Medicine

Volumn 22, Issue , 2016, Pages 156-161

  Shenhar Tsarfaty, Shani ^a   Toker, Sharon ^b   Shapira, Itzhak ^c   Rogowski, Ori ^b   Berliner, Shlomo ^b   Ritov, Yaacov ^a   Soreq, Hermona ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; HEMOGLOBIN A1C;

AGING; ARTICLE; CHOLINERGIC SYSTEM; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 84987647999     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2016.00067     Document Type: Article

References (39)

1. Wang PS, Simon G, Kessler RC. (2003) The economic burden of depression and the cost-effectiveness of treatment. Int J Methods Psychiatr Res 12:22–33.
2. Raison CL, Miller AH. (2012) The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol. Psychiatry.
3. Pavlov VA, Tracey KJ. (2012) The vagus nerve and the inflammatory reflex—linking immunity and metabolism. Nat Rev Endocrinol 8:743–54.
4. Knol MJ, et al. (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49:837–45.
5. Shenhar-Tsarfaty S, et al. (2015) Fear and C-reactive protein cosynergize annual pulse increases in healthy adults. Proc. Natl. Acad. Sci. U. S. A. 112: E467–71.
6. Kroenke K, Spitzer RL, Williams JB. (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606–13.
7. Ellman GL, Courtney D, Andres VJ, Featherstone RM. (1961) A new and rapid col-orimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:88–95.
8. Breiman L, Friedman JH, Olshen RA, Stone. CJ. (1983) Classification and Regression Trees. Wadsworth
9. Ihaka R, Gentleman R. (1996) R: a language for data analysis and graphics. J Comp Graph. Stat 5:299–314.
10. Dray A, Urban L, Dickenson A. (1994) Pharmacology of chronic pain. Trends Pharmacol Sci 15:190–97.
11. Soreq H. (2015) Checks and balances on cholinergic signaling in brain and body function. Trends Neurosci 38:448–58.
12. Taylor P. (2006) Neurohumoral transmission: the autonomic and somatic motor nervous system. In: Goodman & Gilman’s The Pharmacological Basis of Therapeutics. Brunton LL, Gilman LG, A., Lazo JS, Parker KL (eds.) McGraw-Hill, New York.
13. Murray DR, Schaller M. (2010) Historical Prevalence of Infectious Diseases Within 230 Geopolitical Regions: A Tool for Investigating Origins of Culture. Journal of Cross-Cultural Psychology 41:99–108.
14. You D, Jones G, Wardlaw T. (2011) Levels & Trends in Child Mortality: Estimates Developed by the UN Inter-agency Group for Child Mortality Estimation. http://www.childinfo.org/files/ Child_Mortality_Report_2011.pdf. In: Reports 2011. United Nations Children’s Fund, New York, pp. 1–24.
15. Finch CE, Crimmins EM. (2004) Inflammatory exposure and historical changes in human lifespans. Science 305:1736–39.
16. Haffner SM. (2006) The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. The American journal of cardiology 97:3A-11A.
17. Soreq H, Seidman S. (2001) Acetylcholinesterase— new roles for an old actor. Nature reviews. Neuroscience 2:294–302.
18. Tracey KJ. (2002) The inflammatory reflex. Nature 420:853–9.
19. Ofek K, et al. (2007) Cholinergic status modulations in human volunteers under acute inflammation. J Mol. Med. (Berl) 85:1239–51.
20. Rosas-Ballina M, et al. (2011) Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334:98–101.
21. Lin EH, et al. (2004) Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes care 27:2154–60.
22. Chen GY, Nunez G. (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10:826–37.
23. Mitka M. (2009) Hemoglobin A1c poised to become preferred test for diagnosing diabetes. JAMA: the journal of the American Medical Association 301:1528.
24. Campbell CL, et al. (2011) A role for endosomal proteins in alphavirus dissemination in mosquitoes. Insect Mol Biol 20:429–36.
25. Hwang B, Wu P, Harris RA. (2012) Additive effects of clofibric acid and pyruvate dehydroge-nase kinase isoenzyme 4 (PDK4) deficiency on hepatic steatosis in mice fed a high saturated fat diet. The FEBS journal 279:1883–93.
26. Montgomery SB, Dermitzakis ET. (2011) From expression QTLs to personalized transcriptomics. Nat Rev Genet 12:277–82.
27. Richmond JE, Davis WS, Jorgensen EM. (1999) UNC-13 is required for synaptic vesicle fusion in C. elegans. Nature neuroscience 2:959–64.
28. Wraith DC, et al. (2009) A role for galanin in human and experimental inflammatory demyelin-ation. Proc. Natl. Acad. Sci. U. S. A. 106:15466–71.
29. McElhaney JE, Gavazzi G, Flamaing J, Petermans J. The role of vaccination in successful independent ageing. European Geriatric Medicine.
30. Zimmerman G, et al. (2012) Post-traumatic anxiety associates with failure of the innate immune receptor TLR9 to evade the pro-inflammatory NFjB pathway. Transl Psychiatry.2
31. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nature reviews. Neuroscience 9:46–56.
32. McEwen BS, et al. (2015) Mechanisms of stress in the brain. Nature neuroscience 18:1353–63.
33. Williams GC. (1957) Pleiotropy, natural selection, and the evolution of senescence. Evolution 11:398–411.
34. Ridker PM, Hennekens CH, Buring JE, Rifai N. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. The New England journal of medicine 342:836–43.
35. Meisel C, Meisel A. (2011) Suppressing immuno-suppression after stroke. The New England journal of medicine 365:2134–36.
36. Arbel Y, et al. (2014) Decline in serum cholinesterase activities predicts 2-year major adverse cardiac events. Mol. Med. 20:38–45.
37. Hanin G, et al. (2014) Competing targets of microRNA-608 affect anxiety and hypertension. Hum. Mol. Genet. 23:4569–80.
38. Loewenstein-Lichtenstein Y, et al. (1995) Genetic predisposition to adverse consequences of anti-cholinesterases in ‘atypical’ BCHE carriers. Nat. Med. 1:1082–5.
39. Sklan EH, et al. (2004) Acetylcholinesterase/para-oxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study. Proc. Natl. Acad. Sci. U. S. A. 101:5512–17.